DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	49	99	49.4949494949495	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGKV2-29; FCN1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	51	92	55.4347826086957	0	0	0	0	0	0	0
up	TNFRSF13B; LILRA1; TRPA1; IFNG; IL2RA; CD3D; CD3G; CXCR1; LAMA1; KLRC1; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV30; TRBV10-2; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	60	268	22.3880597014925	0	0	0	0	0	0	0
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; TRDV2; TRDV3; LILRA5; CD300LB; TYROBP; LY86; JCHAIN; TRGV3; C4BPA; RNASE3; DEFA4; KLRC2; KIR2DS4; NLRP6; LILRA4; SIGLEC14; NAIP; SLAMF1; CD300E; CLEC6A; TREML4; CLEC10A; ZNF683; LILRA2; IL27; CLEC4C; RNASE6; PLD4; SIGLEC10; CD180; TRGV9; TLR9; TLR8; APOBEC3C; TLR7; TRIM10; CD84; CLEC4A; TRDC; IGHV3-15; IGHV3-66; IGHV4-61; IGHV3-48; IGHV2-70; IGHV1-69-2; IGHV2-26; IGHV4-59; IGHV3-23; IGHV4-39; TRBC1; IGHV3-53; IGHV1-3; TRBC2; IGHV4-4; IGHV3-30; IGLC3; IGHV3-13; IGHV3-49; IFNL1; IGHV1-2; IGHV3-21; IGHV6-1; IGHV5-51; IGHV4-28; IGHV1-58; IGHV3-7; IGHV3-33; IGHV3-72; IGHV1-18; IGHV1-46; IGHA2; IGLL5; IGHV3-64; IGLC2; IGHV3-74; IGHV1-24; IGHV3-73; IGHV4-31; IGHG3; BPI; IGHV3-11; IGHV1-69; IGHV4-34; IGKC; IGHV2-5; IGHD; IGHG2; IGHV3-43; IGHV3-20;	GO:0045087~innate immune response	94	505	18.6138613861386	0	0	0	0	0	0	0
up	TLR9; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	50	98	51.0204081632653	0	0	0	0	0	0	0
down	EVPLL; FOXN1; KRT34; GJB5; KRT14; SPRR1B; SPRR2E; SPRR2D; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KLK7; BNC1; KRT32; KRT31; CST6; CERS3; ACER1; SPRR2F; SPRR2G; CALML5; SPRR3; KLK5; KRTDAP;	GO:0008544~epidermis development	27	82	32.9268292682927	0	0	0	0	0	0	0
down	MUC3A; MUC21; B3GNT6; MUC15; MUCL1; MUC13;	GO:0016266~O-glycan processing	6	60	10	0.00013091316271696	0.00759841815269696	0.179351032922237	0.182362035664727	0.172412635298238	0.179351032922237	0.0593952354854926
up	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.00013582937635292	0.0110376132349399	0.250876858123853	0.253865104403617	0.2507410287475	0.250876858123853	0.0895221291656218
down	ALOX12B; PSAPL1; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.00014181524438183	0.00790194541695599	0.194145069558736	0.1975486354239	0.184785263429534	0.194145069558736	0.061767844227818
down	OVOL1; FOXN1; NKX2-8; SPDEF; IL33; CXCL10; FGF1; HOXD8; HOXB1; PAX1; EPCAM; MMP12; ID4; LUM; FOXF1; FOXF2; HNF4G; HES5; MLIP; VGLL2; TFAP2B; OVOL2; SOX17; NKX1-2; DLX5; HOXC9; DLX3; CCDC160; HOXD9;	GO:0045944~positive regulation of transcription by RNA polymerase II	29	1138	2.54833040421793	0.00017320040083657	0.00893585771723492	0.236764947943592	0.241268158365343	0.216846901847386	0.236764947943592	0.0698497190749686
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00018396971630441	0.00915249338614443	0.251302632471825	0.256269814812044	0.226834660203338	0.251302632471825	0.0715431145042357
down	CYP1A1; CYP2C9; CYP2C19; CYP2C18;	GO:0019373~epoxygenase P450 pathway	4	21	19.047619047619	0.00019883976757306	0.00940966757108623	0.271416282737236	0.276983796229282	0.238210041552534	0.271416282737236	0.0735533909813187
up	TYROBP; CTLA4; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.00019954850477721	0.0155398398095255	0.368366539818737	0.372956155428613	0.367368797294851	0.368366539818737	0.12603807698549
down	UGT1A9; CYP2C9; UGT1A6; FMO3; CYP2C18; CYP2C19; GSTA1;	GO:0006805~xenobiotic metabolic process	7	94	7.4468085106383	0.00020264897855892	0.00940966757108623	0.276413206754378	0.282290027132587	0.241152284485124	0.276413206754378	0.0735533909813187
down	CTSV; MMP7; MMP12; KLK7; TPSAB1; KLK5;	GO:0022617~extracellular matrix disassembly	6	66	9.09090909090909	0.00021208486528201	0.00953013604315631	0.289071671379385	0.295434217337845	0.248139292379956	0.289071671379385	0.0744950676728865
down	KRT16; KRT3; KRT6C; EVPLL;	GO:0045104~intermediate filament cytoskeleton organization	4	22	18.1818181818182	0.00023280673939818	0.0101343683744272	0.317082779060326	0.32429978798167	0.263537228998744	0.317082779060326	0.0792182246356345
down	IL20RB; IL36RN; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	4	25	16	0.00035964249343734	0.0143137712388061	0.488754148581345	0.500981993358214	0.348512367461856	0.488754148581345	0.111887737201276
down	KRT6A; KRT6B; KRT16; KRT4; CCL11; KRT76; KRT31; PAK5;	GO:0007010~cytoskeleton organization	8	139	5.75539568345324	0.00038024511765022	0.0147133735801878	0.516372869769004	0.529681448886762	0.358190900826511	0.516372869769004	0.115011344600863
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.00042703550994194	0.0160773098743007	0.579487186991215	0.594860465349125	0.378353461808561	0.579487186991215	0.125672947548746
up	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.00047168789519713	0.035263387044938	0.870264166638718	0.881584676123449	0.744795186516279	0.870264166638718	0.286008707014769
up	FFAR3; NCR3; IL18RAP; LY86; ORM1; FOLR2; AZU1; CRHBP; CD40LG; FCGR2B; CNR2; CXCR3; AIF1; NLRP6; FUT7; NAIP; IL27; PLD4; CD180; PROK2; TLR9; STAB1; PF4; PTGDR; CCL23; PF4V1; CCL26; CCR5; XCL1; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	32	381	8.3989501312336	0.0005009299324894	0.036009155531642	0.923714795510458	0.936238043822693	0.773435815763637	0.923714795510458	0.292057368203859
down	SCGB1A1; UGT1A1; SERPINB3; UGT1A7; UGT1A8;	GO:0043086~negative regulation of catalytic activity	5	52	9.61538461538462	0.00056640272677965	0.020763131536949	0.768042097513216	0.788998998404063	0.432731683259659	0.768042097513216	0.162301029276156
down	IL33; SCGB1A1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.00059693559750706	0.0207882821831835	0.808847734622072	0.831531287327341	0.442926213350242	0.808250799024565	0.162497626584397
down	CXCL11; CXCL10; APLNR; BDKRB1;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	4	29	13.7931034482759	0.00059693559750706	0.0207882821831835	0.808847734622072	0.831531287327341	0.442926213350242	0.808250799024565	0.162497626584397
down	KRT6A; S100A8; FGF1; EPB41L4B; SPRR3; EVPLL;	GO:0042060~wound healing	6	82	7.31707317073171	0.00062774587414438	0.020820238159122	0.848712421843203	0.874450002683123	0.452866577597526	0.848712421843203	0.162747419722638
up	LTF; SEMG1; ELANE; RNASE3; DEFA4; BPI; AZU1; DEFA3; RNASE6;	GO:0019730~antimicrobial humoral response	9	52	17.3076923076923	0.0008138826481493	0.0563387655330016	1	1	0.977473060427309	0.999999950286819	0.456943556339834
down	FGF1; ADRA2C; NTF3; DYNAP;	GO:0032148~activation of protein kinase B activity	4	32	12.5	0.0008356290324617	0.0258673609382034	1	1	0.520596887223642	0.988016130358214	0.202199716235346
down	SAA1; EDN2; EDNRB;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.00098027795267063	0.0296853736537	1	1	0.556016654878531	0.988016130358214	0.232044318067772
up	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.00106652356409964	0.0687356048724907	1	1	0.999999950286819	0.999999950286819	0.557489881797419
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.00113471581837021	0.0335448063366978	1	1	0.588313340833728	0.988016130358214	0.262212691068631
down	EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.00116606241208617	0.0335448063366978	1	1	0.592390927207498	0.988016130358214	0.262212691068631
down	HES5; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	4	36	11.1111111111111	0.00124913530286941	0.0335448063366978	1	1	0.602283506542004	0.988016130358214	0.262212691068631
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00125337866565156	0.0780854908700923	1	1	0.999999950286819	0.999999950286819	0.633323459595879
down	AKR1B10; LRAT; ADH1B; RBP1; RDH12;	GO:0001523~retinoid metabolic process	5	63	7.93650793650794	0.00126818223202418	0.0335448063366978	1	1	0.604770467827215	0.988016130358214	0.262212691068631
down	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.00137261590896753	0.0335448063366978	1	1	0.617077545123819	0.988016130358214	0.262212691068631
down	EDN3; EDN2; ACE2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.00137261590896753	0.0335448063366978	1	1	0.617077545123819	0.988016130358214	0.262212691068631
down	ALOX12B; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.00137261590896753	0.0335448063366978	1	1	0.617077545123819	0.988016130358214	0.262212691068631
down	EDN3; EDN2; EDNRB;	GO:0042310~vasoconstriction	3	16	18.75	0.00137261590896753	0.0335448063366978	1	1	0.617077545123819	0.988016130358214	0.262212691068631
down	CLDN17; FXYD3; SLC26A9; CLIC6; GABRQ; GABRA4;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.00142819919378889	0.0343014047749643	1	1	0.62374853717348	0.988016130358214	0.268126861821769
up	LILRA5; ORM1; LPL; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	7	35	20	0.00147462230007167	0.086127158713561	1	1	0.999999950286819	0.999999950286819	0.698546548325891
down	HOXB1; HOXC8; HOXD9; HOXC9; HES2; HES5;	GO:0009952~anterior/posterior pattern specification	6	99	6.06060606060606	0.00157612056244361	0.0365550431558185	1	1	0.641441633074425	0.988016130358214	0.285743078729031
down	KRT6A; KRT16; SERPINB5;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.00160075924802938	0.0365550431558185	1	1	0.644083137532876	0.988016130358214	0.285743078729031
up	TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00169203369499216	0.0958306356345558	1	1	0.999999950286819	0.999999950286819	0.777247975508274
down	GSTA1; KRT3; KRT4; DLX5; DLX3;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.0017415374376013	0.0386150285485944	1	1	0.659863952087321	0.988016130358214	0.301845550985992
down	CLDN1; CYP1A1; S100A8; SCGB1A1; UGT1A1; S100A7; BDKRB1;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.00174640832631834	0.0386150285485944	1	1	0.660142347348332	0.988016130358214	0.301845550985992
down	ALOX12B; GSTA1; ALOXE3;	GO:0043651~linoleic acid metabolic process	3	18	16.6666666666667	0.00185127541727814	0.0390731311555826	1	1	0.671507329869864	0.988016130358214	0.305426442649467
down	KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00185127541727814	0.0390731311555826	1	1	0.671507329869864	0.988016130358214	0.305426442649467
down	EDN2; NPNT; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.00185127541727814	0.0390731311555826	1	1	0.671507329869864	0.988016130358214	0.305426442649467
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00212648111320202	0.107416032447961	1	1	0.999999950286819	0.999999950286819	0.871212981156556
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00212648111320202	0.107416032447961	1	1	0.999999950286819	0.999999950286819	0.871212981156556
up	SPTA1; VCAM1; HLA-DMB; CD40LG; AIF1; NCKAP1L; CLECL1; LILRB2; CD80;	GO:0042102~positive regulation of T cell proliferation	9	61	14.7540983606557	0.00219709778271804	0.108062519892106	1	1	0.999999950286819	0.999999950286819	0.876456409354912
down	MMP7; COL15A1; MMP12; KLK6;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.00228466250511516	0.0454647838517918	1	1	0.716535590180862	0.988016130358214	0.355388646545561
up	HBA1; HBG2; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.00236153542840511	0.11317204399203	1	1	0.999999950286819	0.999999950286819	0.917897929972821
down	CYP1A1; CYP2C9; UGT1A1;	GO:0008210~estrogen metabolic process	3	20	15	0.0024223748406359	0.0462242212740522	1	1	0.730918856225798	0.988016130358214	0.361325009039067
down	EDN3; EDN2; NMU;	GO:0010460~positive regulation of heart rate	3	20	15	0.0024223748406359	0.0462242212740522	1	1	0.730918856225798	0.988016130358214	0.361325009039067
down	EPCAM; DUOXA2; CCL19;	GO:2000147~positive regulation of cell motility	3	20	15	0.0024223748406359	0.0462242212740522	1	1	0.730918856225798	0.988016130358214	0.361325009039067
down	EDN3; EDNRB; NRTN; OVOL2;	GO:0001755~neural crest cell migration	4	44	9.09090909090909	0.00246938662909391	0.0464845347882137	1	1	0.735877215469984	0.988016130358214	0.363359824991937
down	CDH16; DSG1; CDH22; PCDHB10;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	4	45	8.88888888888889	0.00266411428202729	0.0481759693839149	1	1	0.756089571804434	0.988016130358214	0.376581413235843
down	CYP2C19; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	3	21	14.2857142857143	0.00274434350899977	0.0481759693839149	1	1	0.763823883487053	0.988016130358214	0.376581413235843
down	CIDEA; EDN2; NMU;	GO:0001659~temperature homeostasis	3	22	13.6363636363636	0.00309145765559937	0.0518843435451798	1	1	0.791958362647638	0.988016130358214	0.405568993565108
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00329877114209154	0.154135081614227	1	1	0.999999950286819	0.999999950286819	1
up	LTF; GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.00344961052185744	0.157251757691501	1	1	0.999999950286819	0.999999950286819	1
down	ELN; HOXD9; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	4	50	8	0.00379690566379443	0.0562669105283578	1	1	0.831198952262417	0.988016130358214	0.439826597288116
down	CXCL11; CXCL10; INHA; ACE2; TFAP2B; BCL6B; GKN1;	GO:0042127~regulation of cell population proliferation	7	163	4.29447852760736	0.00423328051897065	0.0614849708915682	1	1	0.84649568128565	0.988016130358214	0.480615076919286
down	CXCL11; DEFB4A; CXCL14; CXCL10; CCL11; ECSCR;	GO:0006935~chemotaxis	6	122	4.91803278688525	0.00423729878362566	0.0614849708915682	1	1	0.84649568128565	0.988016130358214	0.480615076919286
down	CYP2C9; CYP2C19; CYP2C18;	GO:0042738~exogenous drug catabolic process	3	25	12	0.00428959089652281	0.0615339651694804	1	1	0.848313310049146	0.988016130358214	0.48099805487806
down	DEFB4A; S100A8; S100A7; PGLYRP3;	GO:0019730~antimicrobial humoral response	4	52	7.69230769230769	0.00432902267523982	0.0615339651694804	1	1	0.849238954326853	0.988016130358214	0.48099805487806
down	EDNRB; BDKRB1; NMU; ALOXE3;	GO:0019233~sensory perception of pain	4	53	7.54716981132075	0.00461299399216386	0.062924416654358	1	1	0.85916527125226	0.988016130358214	0.491866921491587
down	PLA2G4E; PLA2G4F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	3	26	11.5384615384615	0.00474304648148427	0.062924416654358	1	1	0.863511388392574	0.988016130358214	0.491866921491587
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00479781846763405	0.195601757173557	1	1	0.999999950286819	0.999999950286819	1
up	APOA2; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00479781846763405	0.195601757173557	1	1	0.999999950286819	0.999999950286819	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00479781846763405	0.195601757173557	1	1	0.999999950286819	0.999999950286819	1
up	ABRA; GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	6	33	18.1818181818182	0.00481416844835936	0.195601757173557	1	1	0.999999950286819	0.999999950286819	1
up	FCN1; SIGLEC5; TYROBP; FCGR3B; TRPM2; HP; ORM1; LTF; ELANE; RNASE2; FCGR2A; RNASE3; DEFA4; BPI; CD53; ORM2; AZU1; MMP8; FCAR; CXCR1; CEACAM8; CEACAM3; MNDA; P2RX1; HK3; NCKAP1L; SIGLEC14; CLEC12A; LILRB2; CLEC4C; MS4A3; ADGRE3; RETN; CD300A;	GO:0043312~neutrophil degranulation	34	483	7.03933747412008	0.00512671152547928	0.203868592364272	1	1	0.999999950286819	0.999999950286819	1
down	EDNRB; NTF3; NTF4;	GO:0007422~peripheral nervous system development	3	27	11.1111111111111	0.00522437180287283	0.0680144852467463	1	1	0.880766122113819	0.988016130358214	0.531654916388249
down	PLA2G4E; PLA2G4F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	3	27	11.1111111111111	0.00522437180287283	0.0680144852467463	1	1	0.880766122113819	0.988016130358214	0.531654916388249
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00543297444520141	0.207229168124111	1	1	0.999999950286819	0.999999950286819	1
up	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.00543297444520141	0.207229168124111	1	1	0.999999950286819	0.999999950286819	1
down	CYP1A1; CLDN18; FOXF1;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.00573402126392308	0.0722837431943051	1	1	0.898707812446916	0.988016130358214	0.565026807227603
down	UGT1A9; CYP1A1; HMGCS2; ACER1; PSAPL1;	GO:0019216~regulation of lipid metabolic process	5	92	5.43478260869565	0.00593810984496734	0.0725595352108729	1	1	0.905499299748145	0.988016130358214	0.567182615376072
down	ADGRL2; CXCL10; INHA; EDN3; MIF; EDN2; EDNRB; ADGRF4; CBLC;	GO:0007166~cell surface receptor signaling pathway	9	268	3.35820895522388	0.00600853040697913	0.0727815900601907	1	1	0.907288091453848	0.988016130358214	0.568918371398034
down	ADRA2C; EDNRB; TMEM100;	GO:0051930~regulation of sensory perception of pain	3	29	10.3448275862069	0.00627242097405833	0.0743700316701835	1	1	0.916596104892117	0.988016130358214	0.581334885149254
down	CYP1A1; MT1A; MT1M;	GO:0071280~cellular response to copper ion	3	29	10.3448275862069	0.00627242097405833	0.0743700316701835	1	1	0.916596104892117	0.988016130358214	0.581334885149254
down	PTPRZ1; GABRA4; KLK6; SH3GL3; ROBO2; SPINK6;	GO:0007417~central nervous system development	6	133	4.51127819548872	0.00629983039273629	0.0743700316701835	1	1	0.918562205503212	0.988016130358214	0.581334885149254
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00664624015840021	0.243565154040196	1	1	0.999999950286819	0.999999950286819	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.00664624015840021	0.243565154040196	1	1	0.999999950286819	0.999999950286819	1
down	DEFB4A; KRT6A; LCE3A; PGLYRP4; PGLYRP3;	GO:0050830~defense response to Gram-positive bacterium	5	95	5.26315789473684	0.00674147950722803	0.0789149659963752	1	1	0.933246088919953	0.988016130358214	0.616861680219677
down	CAPN8; GKN1; CYP39A1;	GO:0007586~digestion	3	30	10	0.00683996951173649	0.0792445599232178	1	1	0.937075823107899	0.988016130358214	0.619438046577254
down	APLNR; FOXF1; SOX17; TMEM100;	GO:0001570~vasculogenesis	4	60	6.66666666666667	0.00695685621384068	0.0792445599232178	1	1	0.939960089559665	0.988016130358214	0.619438046577254
down	FGF1; EDN3; MIF; TPD52L1;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.00695685621384068	0.0792445599232178	1	1	0.939960089559665	0.988016130358214	0.619438046577254
down	ALOX12B; CERS3; ALOXE3;	GO:0046513~ceramide biosynthetic process	3	31	9.67741935483871	0.00743703867098144	0.0822205941958504	1	1	0.956357261213613	0.988016130358214	0.642701080130253
down	FGF1; S100A7; APLNR; COL15A1; ECSCR; OVOL2; SOX17; TMEM100;	GO:0001525~angiogenesis	8	230	3.47826086956522	0.00768555052673647	0.0842989912105819	1	1	0.95921865924798	0.988016130358214	0.658947472161009
up	PF4; LTF; SEMG1; RNASE3; DEFA4; DEFA3; RNASE6; PF4V1;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.00779322935413174	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
up	LILRA5; IFNG; LPL; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	6	37	16.2162162162162	0.00783166309195571	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
up	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.00804668353361349	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
down	SLC6A14; SLC6A1; SLC6A11;	GO:0006810~transport	3	32	9.375	0.008063974192555	0.0864085850017624	1	1	0.963090734569715	0.988016130358214	0.675437722827383
down	SCNN1G; UGT1A7; ATP6V0A4;	GO:0007588~excretion	3	32	9.375	0.008063974192555	0.0864085850017624	1	1	0.963090734569715	0.988016130358214	0.675437722827383
up	HP; HBZ; HBD; HBG1; HBG2; HBA1; HBM; LOXHD1; CYGB;	GO:0098869~cellular oxidant detoxification	9	77	11.6883116883117	0.00869624063561558	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
down	SAA1; CCL19; CCL11;	GO:0048247~lymphocyte chemotaxis	3	33	9.09090909090909	0.00872109647984254	0.0906603537046318	1	1	0.970083472576492	0.988016130358214	0.708672903921902
up	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.00886214965465526	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
up	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.00886214965465526	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
up	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.00886214965465526	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
up	IFNG; AZU1; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.00922083829966081	0.274202172559408	1	1	0.999999950286819	0.999999950286819	1
down	EDN2; FOXF1; ABCA12;	GO:0048286~lung alveolus development	3	34	8.82352941176471	0.00940870129949123	0.096370006692583	1	1	0.977315318485279	0.988016130358214	0.753304059636785
down	CXCL11; CXCL14; GNA14; CXCL10; INHA; FGF1; CGB7; SCGB1A1; EDN3; NTF3; COL15A1; CCL11; FAM3B; FGFBP1; SH3GL3; CALML5; PAK5; GABRQ; HTR3B; GABRA4; CBLC;	GO:0007165~signal transduction	21	989	2.12335692618807	0.00969086673846276	0.0985356012166323	1	1	0.979134143519681	0.988016130358214	0.770232056245704
down	KLK8; BRINP1; CIDEA;	GO:0008219~cell death	3	35	8.57142857142857	0.0101270604678754	0.10076425165536	1	1	0.983017028424584	0.988016130358214	0.787652947668492
down	CXCL10; EDN3; ELN;	GO:0008015~blood circulation	3	36	8.33333333333333	0.0108764225220191	0.107452883497679	1	1	0.988016130358214	0.988016130358214	0.839936575045497
up	SPI1; IRF4; BATF; BATF3;	GO:0043011~myeloid dendritic cell differentiation	4	18	22.2222222222222	0.0114034757908372	0.302811293463354	1	1	0.999999950286819	0.999999950286819	1
up	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.0114595736625693	0.302811293463354	1	1	0.999999950286819	0.999999950286819	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0114595736625693	0.302811293463354	1	1	0.999999950286819	0.999999950286819	1
up	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0114595736625693	0.302811293463354	1	1	0.999999950286819	0.999999950286819	1
up	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0114595736625693	0.302811293463354	1	1	0.999999950286819	0.999999950286819	1
down	CXCL11; CXCL10; CCL11; CCL19;	GO:0070098~chemokine-mediated signaling pathway	4	70	5.71428571428571	0.0114941795744319	0.108981339831236	1	1	0.988016130358214	0.988016130358214	0.851884196515724
down	EPCAM; NPNT; ROBO2;	GO:0001657~ureteric bud development	3	37	8.10810810810811	0.0116570133774976	0.108981339831236	1	1	0.988016130358214	0.988016130358214	0.851884196515724
down	SAA1; SAA2; UGT1A1;	GO:0006953~acute-phase response	3	37	8.10810810810811	0.0116570133774976	0.108981339831236	1	1	0.988016130358214	0.988016130358214	0.851884196515724
down	AGR2; FOXF1; NPNT;	GO:0010811~positive regulation of cell-substrate adhesion	3	37	8.10810810810811	0.0116570133774976	0.108981339831236	1	1	0.988016130358214	0.988016130358214	0.851884196515724
up	ORM1; BPI; NCKAP1L; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	5	29	17.2413793103448	0.0119123301017002	0.309224235556635	1	1	0.999999950286819	0.999999950286819	1
down	MUC3A; MUC21; MUC15; MUCL1; MUC13;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	5	112	4.46428571428571	0.012765437183879	0.118548359980956	1	1	0.988016130358214	0.988016130358214	0.926667579486747
up	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.0133642821639013	0.342162237867555	1	1	0.999999950286819	0.999999950286819	1
down	CXCL11; DEFB4A; GPR37; ADGRL2; GNA14; CXCL10; SAA1; EDN3; ADRA2C; EDN2; EDNRB; APLNR; BDKRB1; NMU; PREX2; ADGRF4; QRFPR; CCL19; FZD10; CCL11; CGB7; GPR87; MRGPRX3;	GO:0007186~G protein-coupled receptor signaling pathway	23	1152	1.99652777777778	0.0135909747629999	0.122936544447135	1	1	0.988016130358214	0.988016130358214	0.960969093892078
down	CXCL14; SAA2; SAA1; DEFB4A;	GO:0060326~cell chemotaxis	4	74	5.40540540540541	0.0137375031788931	0.123460270504504	1	1	0.988016130358214	0.988016130358214	0.965062950255624
down	SYNPO2L; MYOZ1; TNNT2;	GO:0045214~sarcomere organization	3	40	7.5	0.0141880920031061	0.126692385643121	1	1	0.988016130358214	0.988016130358214	0.990327714041522
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0144488389503585	0.343411715425166	1	1	0.999999950286819	0.999999950286819	1
up	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0144488389503585	0.343411715425166	1	1	0.999999950286819	0.999999950286819	1
up	IL2RA; CTLA4; CLEC4G; LILRB2; LILRB1; CD80;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.0146078413416779	0.343411715425166	1	1	0.999999950286819	0.999999950286819	1
down	CXCL10; EDNRB; IL36B; CXCL11; IL36RN; IL36G;	GO:0071222~cellular response to lipopolysaccharide	6	163	3.68098159509202	0.0155003543932467	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
up	CEACAM4; ICAM3; IRF8; SLAMF1; CEBPE; PLD4; ELANE;	GO:0006909~phagocytosis	7	57	12.280701754386	0.0156179752868588	0.343411715425166	1	1	0.999999950286819	0.999999950286819	1
up	FOLR2; CCR2; CCL23; CCL26; XCL2; XCL1;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.016039387372654	0.348576918598724	1	1	0.999999950286819	0.999999950286819	1
down	SCGB1A1; DUOXA2; ACE2; BCL6B;	GO:0050727~regulation of inflammatory response	4	78	5.12820512820513	0.0162408147714272	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	CDH16; CEACAM5; DSG1; ROBO2; CDH22; PCDHB10;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	6	165	3.63636363636364	0.0163322875387728	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	CLDN1; KRT14; CYP1A1; KRT16; MMP7; EDNRB;	GO:0007568~aging	6	166	3.6144578313253	0.0167595849030651	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
up	LTF; MS4A1; CCR2; CCR6; JCHAIN; IFNG; AIRE;	GO:0006959~humoral immune response	7	58	12.0689655172414	0.016901504062996	0.363090932111948	1	1	0.999999950286819	0.999999950286819	1
down	DLX3; FOXF1; APLNR;	GO:0001568~blood vessel development	3	43	6.97674418604651	0.0170063236066864	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	SCGB1A1; IL20RB; VTCN1;	GO:0042130~negative regulation of T cell proliferation	3	43	6.97674418604651	0.0170063236066864	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	DEFB4A; S100A7; LCE3A; NLRP10;	GO:0050829~defense response to Gram-negative bacterium	4	80	5	0.0175926493381591	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
up	ELANE; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0178369309553876	0.37584198126465	1	1	0.999999950286819	0.999999950286819	1
up	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.0178972372030786	0.37584198126465	1	1	0.999999950286819	0.999999950286819	1
down	HOXB1; HOXD9; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	3	44	6.81818181818182	0.0180100732271946	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	LIPK; LIPI; PLA2G3; PNLIPRP3;	GO:0016042~lipid catabolic process	4	81	4.93827160493827	0.0182940341499814	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	CYP1A1; FOXF1; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	3	45	6.66666666666667	0.0190461190005919	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
up	AZU1; CCR6; CCR5; CXCR5; CXCR3; CXCR1; CCR2; CCR8;	GO:0060326~cell chemotaxis	8	74	10.8108108108108	0.0192018276707776	0.398757954629815	1	1	0.999999950286819	0.999999950286819	1
down	KLK8; PAK5; NTF3; NTF4;	GO:0007613~memory	4	83	4.81927710843374	0.0197482883222149	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	EDN2; EDNRB; CALML5; CALML3;	GO:0019722~calcium-mediated signaling	4	85	4.70588235294118	0.0212718648639204	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	RHOD; CLDN1; FGF1; NTF3; SERPINB3; CCL11; FOXF1;	GO:0030335~positive regulation of cell migration	7	226	3.09734513274336	0.021327636929253	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0216278259992533	0.434828251645278	1	1	0.999999950286819	0.999999950286819	1
up	XCL1; NCKAP1L; XCL2; CXCR1; PF4; CCL26; CCL23; PF4V1;	GO:0030593~neutrophil chemotaxis	8	76	10.5263157894737	0.0218824590548663	0.434828251645278	1	1	0.999999950286819	0.999999950286819	1
down	HOXD9; NTF4; PREX2;	GO:0008344~adult locomotory behavior	3	48	6.25	0.0223484467473296	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
down	RHOD; SAA1; EPB41L4B;	GO:0045785~positive regulation of cell adhesion	3	48	6.25	0.0223484467473296	0.128018266409226	1	1	0.988016130358214	0.988016130358214	1
up	CD300LD; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0230462529574171	0.439524967116455	1	1	0.999999950286819	0.999999950286819	1
up	POMC; ORM1; BPI; LILRA4; SLAMF1; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	6	49	12.2448979591837	0.0246573700809253	0.465501259406559	1	1	0.999999950286819	0.999999950286819	1
up	JCHAIN; IGKV3-20; IGHA2;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.0258227988017121	0.477283735464091	1	1	0.999999950286819	0.999999950286819	1
up	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0258227988017121	0.477283735464091	1	1	0.999999950286819	0.999999950286819	1
up	PF4; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0263029559940082	0.477283735464091	1	1	0.999999950286819	0.999999950286819	1
up	PF4; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.0263029559940082	0.477283735464091	1	1	0.999999950286819	0.999999950286819	1
down	GABRQ; HTR3B; GABRA4;	GO:0050877~nervous system process	3	52	5.76923076923077	0.027204856100255	0.145196799033162	1	1	0.988016130358214	0.988016130358214	1
down	ARHGEF15; CALML3; CALML5;	GO:0050790~regulation of catalytic activity	3	53	5.66037735849057	0.0284997145960799	0.150244956235746	1	1	0.988016130358214	0.988016130358214	1
up	CD40LG; XCL1; TIGIT; TLR9;	GO:0032733~positive regulation of interleukin-10 production	4	25	16	0.029548737534649	0.499651472114591	1	1	0.999999950286819	0.999999950286819	1
up	HBZ; EPB42; TAL1;	GO:0043249~erythrocyte maturation	3	14	21.4285714285714	0.0304207068862674	0.499651472114591	1	1	0.999999950286819	0.999999950286819	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.0304207068862674	0.499651472114591	1	1	0.999999950286819	0.999999950286819	1
up	CD3G; CD80; SLA; GRAP; SKAP1; FCRL2; ROPN1B;	GO:0009967~positive regulation of signal transduction	7	67	10.4477611940298	0.0319387431285033	0.514599231958385	1	1	0.999999950286819	0.999999950286819	1
down	CLDN1; CLEC3B; OVOL2;	GO:0071560~cellular response to transforming growth factor beta stimulus	3	56	5.35714285714286	0.032577032497173	0.150244956235746	1	1	0.988016130358214	0.988016130358214	1
up	GPR65; P2RY10; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.0333015142406508	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	MMP8; SCIMP; LILRB2; TLR9; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.033441620558311	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
down	PLA2G4E; PLA2G4F; PLA2G3;	GO:0006644~phospholipid metabolic process	3	57	5.26315789473684	0.0340000660773854	0.150244956235746	1	1	0.988016130358214	0.988016130358214	1
up	NLRP6; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.0354182533745029	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.0354182533745029	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	IFNG; FCER2; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.0354182533745029	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	JCHAIN; IGKC; IGHG3; IGHA2; LTF;	GO:0001895~retina homeostasis	5	40	12.5	0.0362435809498534	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	RCVRN; CABP4; TRPC3; GPR88;	GO:0007602~phototransduction	4	27	14.8148148148148	0.0367206594334399	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
down	SAA1; EDN2; EDNRB; BDKRB1; NMU;	GO:0007204~positive regulation of cytosolic calcium ion concentration	5	150	3.33333333333333	0.0372235840016254	0.157924309243987	1	1	0.988016130358214	0.988016130358214	1
down	CXCL10; NTF3; CARD18; DYNAP; CIDEA; CIDEC;	GO:0042981~regulation of apoptotic process	6	202	2.97029702970297	0.0376385440694185	0.158150315176053	1	1	0.988016130358214	0.988016130358214	1
up	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0408102295782329	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.0408102295782329	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.0408102295782329	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
down	KLK8; CYP1A1; KLK6;	GO:0009611~response to wounding	3	62	4.83870967741935	0.0415890589483894	0.158150315176053	1	1	0.988016130358214	0.988016130358214	1
down	KLK8; NTF3; NTF4;	GO:0048812~neuron projection morphogenesis	3	62	4.83870967741935	0.0415890589483894	0.158150315176053	1	1	0.988016130358214	0.988016130358214	1
down	SCNN1G; FXYD3; ATP6V0A4; GABRQ; GABRA4; HTR3B;	GO:0034220~ion transmembrane transport	6	208	2.88461538461538	0.0422378260517442	0.158150315176053	1	1	0.988016130358214	0.988016130358214	1
down	MIF; S100A7; SYT14P1; NPNT; CCL19; CCL11;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	6	209	2.87081339712919	0.0430371698548779	0.158150315176053	1	1	0.988016130358214	0.988016130358214	1
up	GATA1; NCKAP1L; RHAG;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.0465897387151387	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
up	AIF1; P2RY12; CCL26;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.0465897387151387	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
down	FOXN1; TREH; ELN; LAMB4;	GO:0009887~animal organ morphogenesis	4	111	3.6036036036036	0.0476238662933761	0.162200600847611	1	1	0.988016130358214	0.988016130358214	1
down	KRT75; PTPRZ1; SERPINB12;	GO:0002244~hematopoietic progenitor cell differentiation	3	66	4.54545454545455	0.048219270739311	0.163399060189841	1	1	0.988016130358214	0.988016130358214	1
up	TRPM2; CCR5; TRPC3; CACNG6; NMUR1; TRPV5; TRPC5;	GO:0006816~calcium ion transport	7	74	9.45945945945946	0.0484564055164701	0.517282895448185	1	1	0.999999950286819	0.999999950286819	1
